Notice: This company has been marked as potentially delisted and may not be actively trading. First Wave BioPharma (FWBI) News Today Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period ENTO Entero Therapeutics, Inc.September 2, 2024 | seekingalpha.comHow to trade Cryptos using Elliott WaveJuly 22, 2024 | fxstreet.comEntero Therapeutics to Present Corporate Update at 2024 BIO International ConventionMay 22, 2024 | finance.yahoo.comEntero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease Week (DDW) ConferenceMay 20, 2024 | finance.yahoo.comFirst Wave BioPharma Changes Name to Entero TherapeuticsMay 16, 2024 | finance.yahoo.comFWBI Stock Earnings: First Wave BioPharma Beats EPS for Q1 2024May 15, 2024 | investorplace.comFirst Wave BioPharma, Inc. to raise approximately $1.1 million of Gross Proceeds Priced At-the-MarketMay 10, 2024 | globenewswire.comFirst Wave BioPharma and Celiac Journey to Host Nasdaq Event in Support of Celiac Disease Awareness MonthMay 9, 2024 | globenewswire.comFirst Wave BioPharma Announces Invited Paper for Special Edition on Celiac Disease in Peer-Reviewed Scientific Journal, NutrientsApril 24, 2024 | globenewswire.comFirst Wave BioPharma CEO James Sapirstein to Present at the Planet MicroCap ShowcaseApril 17, 2024 | finance.yahoo.comFirst Wave BioPharma CEO James Sapirstein to Participate in 2024 Longwood Healthcare Leaders ConferenceApril 15, 2024 | globenewswire.comFirst wave BioPharma CEO sells shares to cover tax obligationsApril 5, 2024 | investing.comFirst wave BioPharma CFO sells shares worth over $5,500March 21, 2024 | investing.comFirst wave BioPharma CEO sells shares worth over $9,000March 21, 2024 | investing.comFirst Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) ConferenceMarch 18, 2024 | globenewswire.comWhy Is First Wave BioPharma (FWBI) Stock Up Today?March 14, 2024 | investorplace.comFirst Wave BioPharma Completes Merger Deal With ImmunogenX Adding Phase 3-Ready Candidate For Celiac DiseaseMarch 14, 2024 | msn.comFirst Wave BioPharma Announces Completion of Business Combination with ImmunogenX, Adding Phase 3-Ready Latiglutenase to its Late-Stage GI-Focused Clinical PipelineMarch 14, 2024 | globenewswire.comFirst Wave BioPharma to Participate In ‘Fireside Chat’ at the 36th Annual Roth ConferenceMarch 5, 2024 | finance.yahoo.comFirst Wave BioPharma to Participate In ‘Fireside Chat' at the 36th Annual Roth ConferenceMarch 5, 2024 | globenewswire.comFirst Wave BioPharma Shares Drop 25% After Direct Offering PricesMarch 4, 2024 | marketwatch.comFirst Wave Biopharma to raise about $4M of proceeds in direct offeringMarch 4, 2024 | msn.comFirst Wave BioPharma, Inc. to Raise Approximately $4.0 Million of Gross Proceeds in Registered Direct OfferingMarch 4, 2024 | finance.yahoo.comFirst Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024February 13, 2024 | finance.yahoo.comFirst Wave BioPharma to Present at the DealFlow MicroCap ConferenceJanuary 23, 2024 | finance.yahoo.comThis BioPharma Could Be First To Market With Its Celiac Therapy – Phase 3 Clinical Trials To Commence In 2024January 22, 2024 | benzinga.comFirst Wave BioPharma files to sell 1.76M for holdersJanuary 8, 2024 | msn.comFirst Wave expecting "significant" investments if ImmunogenX deal closesJanuary 6, 2024 | msn.comFirst Wave BioPharma Chairman and CEO Issues Letter to Shareholders Highlighting Recent Accomplishments and Outlook for 2024January 4, 2024 | finance.yahoo.comWhat's Going On With First Wave BioPharma Stock?January 3, 2024 | msn.comTrading was temporarily halted for "FWBI" at 09:01 AM with a stated reason of "LULD pause."January 3, 2024 | marketbeat.comFirst Wave BioPharma price target set at $40 at Roth MKMJanuary 3, 2024 | realmoney.thestreet.comBuy Rating Affirmed for First Wave BioPharma Amid Strategic Focus on Celiac TreatmentJanuary 3, 2024 | markets.businessinsider.comTrading was temporarily halted for "FWBI" at 12:12 PM with a stated reason of "LULD pause."December 28, 2023 | marketbeat.comTrading was temporarily halted for "FWBI" at 12:12 PM with a stated reason of "LULD pause."December 28, 2023 | marketbeat.comCrude Oil Falls Over 1%; First Wave BioPharma Shares Spike HigherDecember 27, 2023 | markets.businessinsider.comWhy First Wave BioPharma Shares Are Skyrocketing TodayDecember 27, 2023 | msn.comFirst Wave BioPharma Announces Exercise of Warrants and Issuance of New Warrants in a Private Placement for $4.8 Million Gross Proceeds PricedDecember 27, 2023 | finance.yahoo.comTrading was temporarily halted for "FWBI" at 12:12 PM with a stated reason of "LULD pause."December 27, 2023 | marketbeat.comTrading was temporarily halted for "FWBI" at 11:12 AM with a stated reason of "LULD pause."December 27, 2023 | marketbeat.comTrading was temporarily halted for "FWBI" at 09:12 AM with a stated reason of "LULD pause."December 27, 2023 | marketbeat.comTrading was temporarily halted for "FWBI" at 09:12 AM with a stated reason of "LULD pause."December 27, 2023 | marketbeat.comTrading was temporarily halted for "FWBI" at 09:12 AM with a stated reason of "LULD pause."December 27, 2023 | marketbeat.comFirst Wave BioPharma To Sell Niclosamide Program To Undisclosed Biopharmaceutical CompanyDecember 27, 2023 | markets.businessinsider.comFirst Wave BioPharma Announces Streamlining of Clinical Pipeline with Non-Binding Term Sheet to Sell Niclosamide IBD ProgramDecember 27, 2023 | finance.yahoo.comTrading was temporarily halted for "FWBI" at 02:12 PM with a stated reason of "LULD pause." Trading set to resume at 02:12 PM. December 20, 2023 | marketbeat.comFWBI Stock Earnings: First Wave BioPharma Beats EPS for Q3 2023December 20, 2023 | investorplace.comFWBI Stock Earnings: First Wave BioPharma Reported Results for Q1 2023December 20, 2023 | investorplace.comUPDATED: First Wave BioPharma To Acquire ImmunogenX To Bolster Gastrointestinal-Focused PipelineDecember 18, 2023 | finance.yahoo.comFirst Wave BioPharma To Acquire ImmunogenX In All-stock TransactionDecember 18, 2023 | markets.businessinsider.com Get First Wave BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for FWBI and its competitors with MarketBeat's FREE daily newsletter. Email Address Has Trump Finally Gone Too Far? (Ad)Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news. Register For The Webinar To Discover FWBI Media Mentions By Week FWBI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. FWBI News Sentiment▼0.000.55▲Average Medical News Sentiment FWBI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. FWBI Articles This Week▼01▲FWBI Articles Average Week Get First Wave BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for FWBI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PULM News AEON News BTAI News RNXT News ENLV News EQ News GLYC News TPST News BIVI News MIRA News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:FWBI) was last updated on 11/13/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredYou just voted for a financial crisisI’d like to share with you my #1 high-conviction stock to buy before Inauguration Day… and details on the asse...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Wave BioPharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share First Wave BioPharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
